Home Support ISMP Newsletters Webinars Report Errors Educational Store Consulting FAQ Tools About Us Contact Us
ISMP Facebook

The following are excerpts from the newsletter

March 10, 1999

  • Preventing tragedies caused by dislodged syringe caps
  • Placing the therapeutic equivalence code on prescription drug labels and labeling could increase medication errors
  • Safety Briefs
    • Facts and Comparisons CD-ROM contains error on BREVIBLOC infusion rate
    • Vial size of diluent can lead to medication errors due to incorrect reconstitution/dilution of drug.
    • Automatic stop orders may cause problems.
    • Lab mix-up on patient with similar names causes inappropriate treatment.
    • Poison Prevention Week --- March 21-27
    • Severe anal pruritis reported as adverse effect of gemcitabine therapy.
    • REZULIN to again be reviewed by FDA for safety and efficacy data.

March 24, 1999

  • Canadian jury wants safer drug-use systems
  • Hazard Warning! Baxter small volume critical care drug packaging
  • Safety Briefs
    • Fomepizole (ANTIZOL) should only be referred to by these names to avoid confusion.
    • Interpertation of hs needs clear definition for your institution.
    • Teach patients with poor eyesight tactile clues to help them avert medication errors.
    • Make sure of updates to patient allergies.
    • Recent report associates fexofenadine (ALLEGRA) with EKG abnormalities.
    • LACTACARE, a nutritional supplement , confusion with LACTICARE Lotion, a lactic acid-based emollient for external use.

subscribe now

Acute Care Main Page
Current Issue
Past Issues
Highlighted articles
Action Agendas - Free CEs
Special Error Alerts
Newsletter Editions
Acute Care
Long Term Care
ISMP 17th Annual Cheers Awards
Home | Contact UsEmployment  | Legal Notices | Privacy Policy | Help Support ISMP
Med-ERRS Med-ERRS | MSOMedication Safety Officers Society | Consumer Medication SafetyFor consumers
 ISMP Canada ISMP Canada | ISMP Spain ISMP Spain | ISMP Brasil ISMP Brasil | International Group | Pennsylvania Patient Safety Authority

200 Lakeside Drive, Suite 200, Horsham, PA 19044, Phone: (215) 947-7797,  Fax: (215) 914-1492
© 2015 Institute for Safe Medication Practices. All rights reserved